Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 for Gulf War Illness
NCT06515184Phase 3Recruiting
- Sponsor
- University of California, San Diego
- Start
- Sep 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Coenzyme Q10 mucoadhesive tablets in Gulf War syndrome (GWS) (3 arms), sponsored by University of California, San Diego. Primary endpoint: Number of symptoms showing more favorable change on UCSD Symptom Score Survey at 3.5 months. Started Sep 2024; status: recruiting.
02
Drugs
Coenzyme Q10 mucoadhesive tablets
03
Conditions
Gulf War syndrome (GWS)
Beyond the preview
Go deeper on NCT06515184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06515184.